ProberC.G., SullenderW.M., YasukawaL.L., AuD.S., YeagerA.S., ArvinA.M.. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.N Engl J Med1987; 316: 240–4
6.
ArvinA.M., HensleighP.A., ProberC.G.. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery.N Engl J Med1986; 315: 796–800
7.
SullenderW.M., YasukawaL.L., SchwartzM.. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 at delivery, and infants with neonatal herpes.J Infect Dis1988; 157: 164–71
8.
TookeyP., PeckhamC.S.. Neonatal herpes simplex virus infection in the British Isles.Paediatr Perinat Epidemiol1996; 10: 432–42
9.
BrownZ.A., BenedettiJ., AshleyR.. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor.N Engl J Med1991; 324: 1247–52
10.
Centers for Disease Control.Pregnancy outcomes following systemic prenatal acyclovir exposure. June 1, 1984-June 30, 1993.MMWR1993; 42: 806–9
11.
RandolphA.G., WashingtonA.E., ProberC.G.. Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs.JAMA1993; 270: 77–82
12.
ScottL.L., SanchezP.J., JacksonG.L., ZerayF., WendelGDJr. Acyclovir suppression to prevent Cesarean delivery after first-episode genital herpes.Obstet Gynecol1996; 87: 69–73
13.
BrocklehurstP., CarneyO., RossE., MindelA.. The management of recurrent genital herpes infection in pregnancy: a postal survey of obstetric practice.Br J Obstet Gynaecol1995; 102: 791–7
14.
GibbsR., AmsteyM., LezotteD.. Role of Cesarean delivery in preventing neonatal herpes virus infection.JAMA1993; 270: 94–5
15.
LibmanM.D., DascalA., KramerM.S., MendelsonJ.. Strategies for prevention of neonatal infection with herpes simplex virus: a decision analysis.Rev Infect Dis1991; 13: 1093–104
Stray-PedersenB.. Acyclovir in late pregnancy to prevent neonatal herpes simplex (letter).Lancet1990; 336: 756
19.
BrocklehurstP., KinghornG., CarneyO.. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection.Br J Obstet Gynaecol1998; 105: 275–80
20.
VanE.J., PeetersM., TenH.P.. Neonatal herpes policy in The Netherlands. Five years after a consensus conference.J Perinat Med1993; 21: 371–5
21.
VonauB., Low-BeerN., BartonS.E., SmithJ.R.. Antenatal serum screening for genital herpes: a study of knowledge and attitudes of women at a central London hospital.Br J Obstet Gynaecol1997; 104: 347–9
22.
ShenR., ThinR.N.. Herpes simplex virus infection in pregnancy and its management.Int J STD AIDS1992; 3: 316–18
23.
WilsonP., CropperL., SharpI.. Apparent increase in the prevalence of herpes simplex virus type I genital infections among women.Genitourin Med1994; 70: 228
24.
BartonI.G., KinghornG.R., NajemS., Al-OmarL.S., PotterC.W.. Incidence of herpes simplex virus type 1 and 2 isolated in patients with herpes genitalis in Sheffield.Br J Vener Dis1982; 58: 44–7
25.
BrocklehurstP., CowanF.. Genital herpes simplex virus infection pregnancy: new proposals to improve screening and reduce neonatal risk.J Obstet Gynaecol1996; 16: 132
26.
BrownZ.A., VontverL.A., BenedettiJ.. Effects on infants of a first episode of genital herpes during pregnancy.N Engl J Med1987; 317: 1246–51
ScottL.L., DobsonA.T., HollierL.M., LittleB.B.. Prophylactic acyclovir to prevent neonatal herpes — a murine model.Am J Obstet Gynecol1997; 176: S31
30.
ArvinA.M., MaladonadoY.A.. Other virus infections of the fetus and newborn. In: RemingtonJ.S., KleinJ.O., eds. Infectious Diseases of the Fetus and Newborn Infant.Philadelphia: WB Saudners, 1995
SyedA., LundinS., AhmadM.. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled double-blind study.Dermatology1994; 189: 65–8
33.
GarryR., JonesR.. Relationship between cervical condylo-mata, pregnancy and subclinical papillomavirus infection.J Reprod Med1985; 30: 393–6
34.
FifeK.H., RogersR.E., ZwicklB.W.. Symptomatic and asymptomatic cervical infections with human papillomavirus during pregnancy.J Infect Dis1987; 156: 904
35.
HordingU., IversenA.K., SebbelovA., BockJ.E., NorrildB.. Prevalence of human papillomavirus types 11, 16 and 18 in cervical swabs. A study of 1362 pregnant women.Eur J Obstet Gynaecol Reprod Med1990; 35: 191–8
36.
PengT.C., SearleC.P., ShahK.V., RepkeJ.T., JohnsonT.R.. Prevalence of human papillomavirus infections in term pregnancy.Am J Perinatol1990; 7: 189–92
37.
KempE.A., HakenewerthA.M., LaurentS.L., GravittP.E., StoerkerJ.. Human papillomavirus prevalence in pregnancy.Obstet Gynecol1992; 79: 649–56
38.
PuranenM., YliskoskiM., SaarikoskiS., SyranenK., SyrjanenS.. Vertical transmission of human papillomatosis from infected mothers to their newborn babies and persistence of the virus in childhood.Am J Obstet Gynecol1996; 174: 694–9
39.
QuickC.A., KryzyckR.A., WattsS.L.. Relationship between condylomata and laryngeal papillomatosis.Ann Otol1980; 89: 467–71
40.
PakarianF., KayeJ., CasonJ.. Cancer associated human papillomaviruses: perinatal transmission and persistence.Br J Obstet Gynaecol1994; 101: 514–17
41.
ShahK., KashimaH., PolkF., ShahF., AbbeyH., AbramsonA.. Rarity of Caesarean delivery in cases of juvenile-onset respiratory papillomatosis.Obstet Gynecol1986; 68: 795–9
42.
TsengC.J., LiangC.C., SoongY.K., PaoC.C.. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery.Obstet Gynecol1998; 91: 92–6
43.
NewellM-L, ThorneC., PembreyL., NicollA., GoldbergD., PeckhamC.. Antenatal screening of hepatitis B infection and syphilis in the UK.Br J Obstet Gynaecol1999; 106: 66–71
44.
ZhuQ.R., DuanS.C., XuH.F.. Transplacental transmission of hepatitis B virus from mother to infant.Chin J Infect Dis1989; 7: 159
45.
TongN.J., ThursbyM., RakelaJ.. Studies on the maternal-infant transmission of the viruses which cause acute hepatitis.Gastroenterology1981; 80: 999–1004
46.
LarouzeB., SaimotG., LustbaderE.D., LondonW.T., WernerB.G., PayetM.. Host response to hepatitis-B infection in patients with primary hepatic carcinoma and families. A case/control study in Senegal, West Africa.Lancet1976; 2: 534–8
47.
SzmunessW.. Hepatocellular carcinoma and hepatitis B virus: evidence for a causal association.Prog Med Virol1978; 24: 40–69
48.
AndreF.E., ZuckermanA.J.. Review: protective efficacy of hepatitis B vaccines in neonates.J Med Virol1994; 44: 14–51
49.
BoxallE.H., JeffersonT.O., DemicheliV., LaurichesseH., PrattM., DeeksJ.. Vaccines for preventing hepatitis B in high risk newborn infants (Protocol for a Cochrane review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 1999
50.
QirongZ., XinhuanG., Huafang, ShuchengD.. A preliminary study on interruption of HBV transmission in uterus.Chin Med J1997; 110: 145–7
51.
Universal antenatal screening for hepatitis B and immunisation of babies at risk.CDR Wkly1998; 8: 284
52.
ZeldisJ.B., CrumpackerC.S.. Hepatitis. In: RemingtonJ.S., KleinJ.O., eds. Infectious Diseases of the Fetus and Newborn Infant.Philadelphia: WB Saunders, 1995
53.
KimM.J., AlexanderJ.M., SercecleyB., JacksonG., WendelG.D.. Hepatitis B (HBV) transmission associated with breastfeeding in infants of chronic carriers.Am J Obstet Gynecol1997; 176: S36
54.
RooneyG.J., GilsonR.J.C.. Sexual transmission of hepatitis C infection.Sex Transm Infect1998; 74: 399–404
55.
KaldorJ.M., ArcherG.T., BuringM.L.. Risk factors for hepatitis C virus infection in blood donors: a case-control study.Med J Aust1992; 157: 227–30
56.
AtrahH.I., AlaF.A., AhmedM.M.. Unexplained hepatitis C virus antibody seroconversion in established blood donors.Transfusion1996; 36: 339–43
57.
GiacchinoR., TassoL., TimitilliA.. Vertical transmission of hepatitis C virus infection: usefulness of viremia detection in HIV-seronegative hepatitis C virus-positive mothers.J Pediatr1998; 132: 167–9
58.
SpencerJ.D., LattN., BeebyP.J.. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission.J Viral Hepatitis1997; 4: 395–409
59.
MazzaC., RavaggiA., RodellaA.. Prospective study of mother-to-infant transmission of hepatitis C (HCV) infection.J Med Virol1998; 54: 12–19
60.
OhtoH., TerazawaS., SasakiN.. Transmission of hepatitis C virus from mothers to infants.N Engl J Med1994; 330: 744–50
61.
LeikinE., ReinusJ.. Invasive monitoring and vertical transmission of hepatitis C virus.Am J Obstet Gynecol1997; 176: S37
62.
NiederauC., HeintgesT., HaussingerD.. Treatment of hepatitis C with alpha-interferon: an analysis of the literature.Hepato-gastroenterology1996; 43: 1544–56
63.
ZeinN.N.. Vertical transmission of hepatitis C: to screen or not to screen.J Pediatr1997; 130: 859–61